multiple myelomabilateral microcystic epithelial keratopathyBelantamab-mafodotinUCL HospitalNICEFDAGSKBelamaf
… Belantamab-mafodotin (Belamaf, GSK) is a 2nd line biologic for multiple myeloma which has been recently approved by NICE in the UK and FDA in t…